Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.84%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.63%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-9.17%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-7.36%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year6.74%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range56.43 - 77.12 Perf YTD0.62%
Dividend0.93 P/FCF- EPS past 5Y- ROI- 52W High-11.66% Beta-
Dividend %1.37% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.74% ATR1.72
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.08 Volatility2.88% 2.32%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.62 Prev Close67.88
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume14.50M Price68.13
Recom- SMA20-0.85% SMA50-4.47% SMA200-5.55% Volume23,182,100 Change0.37%
Oct-08-15 10:13AM  The FDA Approved Mercks Drug Keytruda for Lung Cancer Treatment
Oct-07-15 04:07PM  XLV Dragged Down by Its Bottom Ten Stocks
03:06PM  Johnson & Johnsons Major Developments in 2Q15
02:36PM  Trading Nation: Consumer staples hot?
02:12PM  Can sick healthcare recover?
02:07PM  How are XLVs Moving Averages Trending?
12:50PM  Wednesday links: addicted to liquidity
11:42AM  Overweight A Struggling Energy ETF? One Research Firm Says Yes
Oct-06-15 02:06PM  Johnson & Johnsons Profitability Improves in 2Q15
02:06PM  How Did Johnson & Johnsons Medical Devices Segment Do in 2Q15?
01:37PM  What will drive Q4?
01:11PM  Health care stocks take a broad beating as sector turns negative on the year at MarketWatch
12:45PM  Tuesday links: meritorious mentors
12:39PM  Energy and materials stocks rise while health care falls, as sectors reverse performance roles at MarketWatch
12:38PM  What's Wrong With Health Care? at
12:01PM  Buy protection at these levels: Trader
09:40AM  Eli Lilly Traded above Its 100-Day Moving Average
09:39AM  XLVs Healthcare Services Stocks Outperformed Other Subgroups
07:53AM  As laggard stocks lead, investors wonder if storm has passed
07:04AM  Sector standouts since August 25th
Oct-05-15 02:45PM  S&P 500 earnings to decline for the third quarter: Estimize
Oct-03-15 08:22AM  One tweet from Hillary Clinton sent these stocks into a tailspin, and now Wall Street thinks it's time to buy
Oct-02-15 01:13PM  Bristol-Myers and Celgene Boost Top Ten Stocks Performance
01:13PM  XLV Gained 1% as 60% of Portfolio Ended Positively for the Day
Oct-01-15 02:26PM  Biotech: buy the dip?
Sep-30-15 05:41PM  Best Investments for the Next 10 Years at Motley Fool
04:09PM  Other Franchises of JNJs Pharmaceuticals Segment in 2Q15
03:08PM  Johnson & Johnsons Pharmaceuticals Segment Grows in 2Q15
01:37PM  Three sectors to like in Q4
10:09AM  Did Johnson & Johnsons Consumer Healthcare Segment Grow in 2Q15?
10:09AM  Johnson & Johnsons Segment Performance in 2Q15
09:45AM  Health Care Sector Tests Bull Market Support Level
08:33AM  Tackling drug pricing reform
Sep-29-15 06:50PM  The personal health metrics movement
01:58PM  Nashville's Startup Scene
01:51PM  Johnson & Johnson's stock paces Dow gainers after analyst upgrade at MarketWatch
10:05AM  Bristol-Myers Squibbs Late-Stage Pipeline in 2Q15
10:05AM  Bristol-Myers Squibbs Cardiovascular Segment in 2Q15
08:36AM  Theranos CEO: Going after a dream
08:31AM  Theranos CEO: Power of preventive care
08:15AM  Politics Trigger Biotech ETF Crash
07:00AM  Icahn: Fed Walking Treacherous Path
Sep-28-15 04:40PM  Health Care Stocks: Not Looking So Good at TheStreet
02:02PM  Johnson & Johnson Stock Remained Neutral to 2Q15 Earnings
10:14AM  Bristol-Myers Squibb and Eli Lilly Shine in XLVs Top Ten
08:07AM  No shelter for U.S. stocks as trapped global investors flail
08:04AM  Bristol-Myers Squibbs Neuroscience and Immunoscience Segments
08:04AM  Why Opdivo Is Key for Bristol-Myers Squibb
07:30AM  Global Mkts on Sale (Again) - Try the Vellutata di Verdura
Sep-26-15 08:47AM  The Week Ahead: Will European Stocks Bottom First? at Forbes
Sep-24-15 07:00AM  The hottest trade of the year could soon cool at CNBC
Sep-23-15 07:56PM  Are The Strongest S&P Sectors Favoring The Bulls?
03:14AM  Bristol-Myers Squibbs Oncology Segment in 2Q15
03:14AM  How Did Bristol-Myers Squibbs Virology Segment Perform in 2Q15?
Sep-22-15 12:36PM  Tuesday links: a bull market built on sand
12:00PM  Dow tumbles triple digits as commodity slide hits sentiment at MarketWatch
10:06AM  Bristol-Myers Squibbs Business Segment Performance
10:05AM  Humana Stock Rises 4.34% August 2531
08:54AM  Protecting pharmaceutical competition
07:04AM  Whats the Outlook for Eli Lilly?
07:04AM  Biogen Stock Rises 6.81% August 2531
06:05AM  Vertex Outperforms XLV on a Year-to-Date Basis
Sep-18-15 11:06AM  Biogen and Gilead Help Biotechnology Outperform
11:06AM  Patterson Companies Was XLVs Worst Performer
07:52AM  Future of health care: 20 years from now
07:41AM  Future of health care: Premature births
07:36AM  Future of health care: Preventive care
07:23AM  Future of health care: In home care
07:20AM  Future of health care: Fee structure
07:16AM  Future of health care: Reducing costs
Sep-17-15 05:36PM  3 things to trade when the Fed chickens out
Sep-16-15 03:39PM  XLV and XBI Outperform Benchmark Indexes from August 2531
Sep-15-15 01:01PM  Markets rally day ahead of FOMC meeting
11:34AM  What Was Bristol-Myers Squibbs Growth Rate in 2Q15?
11:33AM  Bristol-Myers Squibb Stock Reacts Negatively to 2Q15 Earnings
Sep-14-15 01:21PM  Biotechnology Trading below Moving Averages
01:21PM  Vertex Helps Biotechnology Sector Outperform
11:07AM  How Will Vertex Solve Its Falling Revenue Woes?
09:07AM  PerkinElmer and Mallinckrodt Help Bottom Ten Stocks in XLV
Sep-11-15 04:23PM  New York's 'cannabiz'
02:15PM  NY medical marijuana biz set to boom
01:27PM  The Biotech Sector Is in a Downward Long-Term Trend
01:26PM  Vertex and Biogen Outperformd XLV and SPY
01:09PM  Lifesaving blood pressure study
11:53AM  Medical marijuana hits Big Apple
Sep-10-15 04:05PM  Industrial ETFs Are Still Scuffling
01:36PM  Two pros, two sector picks
01:33PM  Health care, financials higher Thursday
01:25PM  Traders bet big on this health-care stock at CNBC
12:59PM  Top trades for the 2nd half
Sep-09-15 11:21AM  Bulls look for pop in health care fund
Sep-08-15 03:32PM  This Giant Healthcare ETF Eyes A Comeback
03:16PM  Market looks a lot like 1998: Wells Fargo at CNBC
01:07PM  What Were Merck & Co.s Profitability Margins?
01:07PM  Analyzing Merck & Co.s Geographical Performance
12:36PM  Health Care Stocks: Time For a Check-Up at TheStreet
10:09AM  Healthy signs from M&A
08:06AM  Merck: Other Human Health Franchise and Animal Health Segment
08:06AM  Mercks Global Human Health Segment Performance
06:51AM  Health care's day of reckoning: Bill George
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.